Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants
- Nan, Hongmei
- Hutter, Carolyn M.
- Lin, Yi
- Jacobs, Eric J.
- Ulrich, Cornelia M.
- White, Emily
- Baron, John A.
- Berndt, Sonja I.
- Brenner, Hermann
- Butterbach, Katja
- Caan, Bette J.
- Campbell, Peter T.
- Carlson, Christopher S.
- Casey, Graham
- Chang-Claude, Jenny
- Chanock, Stephen J.
- Cotterchio, Michelle
- Duggan, David
- Figueiredo, Jane C.
- Fuchs, Charles S.
- Giovannucci, Edward L.
- Gong, Jian
- Haile, Robert W.
- Harrison, Tabitha A.
- Hayes, Richard B.
- Hoffmeister, Michael
- Hopper, John L.
- Hudson, Thomas J.
- Jenkins, Mark A.
- Jiao, Shuo
- Lindor, Noralane M.
- Lemire, Mathieu
Publication date
January 2015
DOIAbstract
Use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer. Prior studies examining a potential differential relationship of aspirin and NSAIDs with colorectal cancer risk according to genetic factors have been limited to analyses of candidate genes or pathways
Add to ORKG